Developer docs
API playgroundTry for free, no card

Search company profiles

NovaMedica

Full company profile

uuid000g2u1

Namestring
NovaMedica
Legal namestring
NovaMedica
Websiteurl
novamedica.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

NovaMedica is a Russian pharmaceutical company founded in 2012 and headquartered in Moscow, operating exclusively in the domestic Russian market. The company commercializes innovative medical products through a full-cycle model that encompasses product registration, GMP-certified manufacturing, and sales via pharmaceutical distribution networks and pharmacy channels.

NovaMedica's product portfolio consists of three proprietary branded pharmaceutical products. Relonova is a Rizatriptan-based treatment for migraine headaches. Difendum is a Diclofenac potassium-based anti-inflammatory analgesic for pain syndromes of various localization. Levroso Long is a fixed-combination insomnia treatment containing Diphenhydramine and Melatonin. All three products are registered brands in the Russian market, though the underlying active pharmaceutical ingredients are generic molecules available from multiple manufacturers. The core technology is GMP (Good Manufacturing Practice) certified pharmaceutical production, which provides regulatory compliance for commercialization in Russia.

The company operates a sales-led go-to-market model, generating revenue through one-time pharmaceutical product sales distributed through Russian pharmacy networks and healthcare providers. Customer access is facilitated through direct contact channels (phone and email) during business hours. NovaMedica serves patient populations with migraine, pain syndromes, and insomnia as its primary use cases. The firm employs 501-1,000 staff and is privately held with no disclosed parent company, institutional investors, or funding rounds in the available data.

Short descriptiontext

NovaMedica is a Russian pharmaceutical company that registers, manufactures, and distributes three proprietary branded drugs (Relonova for migraine, Difendum for pain, Levroso Long for insomnia) via GMP-certified production and domestic pharmacy networks in Russia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMoscow, Russia
HQ citystring
Moscow
HQ countrystring
Russia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical products, migraine treatment drugs, pain management medication, sleep disorder therapy, GMP-certified manufacturing
Industry2 codes
PRIMARYHLAIAAAN
Pain Management & Anesthesiology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAF
Neurology & Psychiatry (CNS) Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Prescription Pharmaceuticals
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

NovaMedica generates revenue through the sale of proprietary pharmaceutical products including treatments for migraine, pain syndromes, and insomnia. The company handles product registration, manufacturing under GMP standards, and commercial distribution within Russia.

novamedica.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Relonova (Релонова)
Description

Migraine treatment drug containing Rizatriptan

novamedica.com
+2 more records
Core offering1 text field

NovaMedica is a Russian pharmaceutical company that promotes and commercializes proprietary pharmaceutical products within Russia. It handles the full lifecycle from product registration and GMP-certified manufacturing to commercial sales. Its current portfolio consists of three drugs: Relonova (Rizatriptan-based migraine treatment), Difendum (Diclofenac potassium-based pain syndrome treatment), and Levroso Long (Diphenhydramine and Melatonin fixed-combination insomnia treatment).

Differentiator
Functional benefit
Problem solved
Product overview1 text field

NovaMedica is a Russian pharmaceutical company that promotes innovative medical products and technologies in Russia, including registration, GMP production, and sales. The company offers a portfolio of three pharmaceutical products: Relonova (for migraine treatment with Risatriptan), Difendum (for pain syndromes with Diclofenac potassium), and Levroso Long (for insomnia treatment with a fixed combination of Diphenhydramine and melatonin).

Product and service3 records
1Relonova (Релонова)
CategoryPrescription pharmaceutical (migraine therapy)
Description

Proprietary branded pharmaceutical for the treatment of migraine headaches, containing Rizatriptan as the active ingredient. Distributed through pharmaceutical wholesalers and pharmacy chains in Russia.

2Difendum (Дифендум)
CategoryPrescription pharmaceutical (anti-inflammatory analgesic)
Description

Proprietary branded pharmaceutical for the treatment of pain syndromes of various localization, containing Diclofenac potassium as the active ingredient. Distributed through pharmaceutical wholesalers and pharmacy chains in Russia.

3Levroso Long (Левросо® Лонг)
CategoryPrescription pharmaceutical (sleep disorder therapy)
Description

Proprietary branded fixed-combination pharmaceutical for the treatment of insomnia, containing Diphenhydramine and Melatonin as active ingredients. Distributed through pharmaceutical wholesalers and pharmacy chains in Russia.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest Russian pharmaceutical manufacturers with a broad branded generics portfolio spanning CNS, pain, and other therapeutic areas. Directly comparable as a domestic Russian pharma producing and commercializing branded products in overlapping indications.

TypeDirect peer
Description

Russian pharmaceutical company focused on branded prescription and OTC products including CNS and pain therapies. Comparable in business model, Russian-market focus, and branded product strategy.

TypeDirect peer
Description

Russian pharma manufacturer and marketer of branded OTC and prescription products. Overlaps with NovaMedica on branded product strategy and Russian market distribution.

TypeDirect peer
Description

Russian pharmaceutical manufacturer with GMP production and a portfolio of branded generics. Comparable as a domestic pharma with integrated manufacturing and sales operations.

TypeBroad incumbent
Description

Major Russian pharmaceutical company with a much broader portfolio across multiple therapeutic areas. Comparable as a Russian pharma incumbent but operates at significantly larger scale with broader R&D.

6Polysan
TypeDirect peer
Description

Russian pharmaceutical manufacturer producing branded products including CNS therapies. Similar in size, GMP manufacturing, and Russian-market focus.

TypeBroad incumbent
Description

Large Russian biopharmaceutical company with manufacturing and sales capabilities. Comparable as a Russian pharma manufacturer, though Biocad focuses more on biologics and biosimilars.

TypeRegional player
Description

European generics and specialty pharma company with established operations in Russia and CIS. Comparable as a producer of branded generics with significant Russian-market presence.

TypeRegional player
Description

Hungarian-headquartered pharma with substantial Russian operations and a CNS-heavy portfolio. Comparable in therapeutic area overlap (CNS) and Russian-market exposure.

TypeRegional player
Description

Slovenian generic pharma manufacturer with a strong presence in Russia/CIS markets. Comparable as a generics manufacturer with meaningful Russian revenue exposure.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NovaMedica

Prescription Pharmaceuticalsnovamedica.com

NovaMedica is a Russian pharmaceutical company that registers, manufactures, and distributes three proprietary branded drugs (Relonova for migraine, Difendum for pain, Levroso Long for insomnia) via GMP-certified production and domestic pharmacy networks in Russia.

What NovaMedica does

NovaMedica is a Russian pharmaceutical company founded in 2012 and headquartered in Moscow, operating exclusively in the domestic Russian market. The company commercializes innovative medical products through a full-cycle model that encompasses product registration, GMP-certified manufacturing, and sales via pharmaceutical distribution networks and pharmacy channels.

NovaMedica's product portfolio consists of three proprietary branded pharmaceutical products. Relonova is a Rizatriptan-based treatment for migraine headaches. Difendum is a Diclofenac potassium-based anti-inflammatory analgesic for pain syndromes of various localization. Levroso Long is a fixed-combination insomnia treatment containing Diphenhydramine and Melatonin. All three products are registered brands in the Russian market, though the underlying active pharmaceutical ingredients are generic molecules available from multiple manufacturers. The core technology is GMP (Good Manufacturing Practice) certified pharmaceutical production, which provides regulatory compliance for commercialization in Russia.

The company operates a sales-led go-to-market model, generating revenue through one-time pharmaceutical product sales distributed through Russian pharmacy networks and healthcare providers. Customer access is facilitated through direct contact channels (phone and email) during business hours. NovaMedica serves patient populations with migraine, pain syndromes, and insomnia as its primary use cases. The firm employs 501-1,000 staff and is privately held with no disclosed parent company, institutional investors, or funding rounds in the available data.

NovaMedica firmographics

Firmographics
Name
NovaMedica
Legal name
NovaMedica
Website
https://novamedica.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
NovaMedica is a Russian pharmaceutical company that registers, manufactures, and distributes three proprietary branded drugs (Relonova for migraine, Difendum for pain, Levroso Long for insomnia) via GMP-certified production and domestic pharmacy networks in Russia.
Ownership category
akta.pro rank

NovaMedica industry classification

Industry
Product category
Prescription Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAN
Pain Management & Anesthesiology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAF
Neurology & Psychiatry (CNS) Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Pharmaceutical products
  • Migraine treatment drugs
  • Pain management medication
  • Sleep disorder therapy
  • GMP-certified manufacturing

Where NovaMedica is headquartered

Location

Headquarters

HQ city
Moscow
HQ country
Russia
HQ region
Europe

Offices1 record

Markets served

NovaMedica business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Pharmaceutical Product Sales: NovaMedica generates revenue through the sale of proprietary pharmaceutical products including treatments for migraine, pain syndromes, and insomnia. The company handles product registration, manufacturing under GMP standards, and commercial distribution within Russia.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

NovaMedica product offering

Product offering

Core offering

NovaMedica is a Russian pharmaceutical company that promotes and commercializes proprietary pharmaceutical products within Russia. It handles the full lifecycle from product registration and GMP-certified manufacturing to commercial sales. Its current portfolio consists of three drugs: Relonova (Rizatriptan-based migraine treatment), Difendum (Diclofenac potassium-based pain syndrome treatment), and Levroso Long (Diphenhydramine and Melatonin fixed-combination insomnia treatment).

Product overview

NovaMedica is a Russian pharmaceutical company that promotes innovative medical products and technologies in Russia, including registration, GMP production, and sales. The company offers a portfolio of three pharmaceutical products: Relonova (for migraine treatment with Risatriptan), Difendum (for pain syndromes with Diclofenac potassium), and Levroso Long (for insomnia treatment with a fixed combination of Diphenhydramine and melatonin).

Differentiator

Problem solved

Functional benefit

Brands

  • Relonova (Релонова): Migraine treatment drug containing Rizatriptan
  • Difendum (Дифендум)
  • Levroso Long (Левросо Лонг)

Products and services

  • Relonova (Релонова) Proprietary branded pharmaceutical for the treatment of migraine headaches, containing Rizatriptan as the active ingredient. Distributed through pharmaceutical wholesalers and pharmacy chains in Russia.
  • Difendum (Дифендум) Proprietary branded pharmaceutical for the treatment of pain syndromes of various localization, containing Diclofenac potassium as the active ingredient. Distributed through pharmaceutical wholesalers and pharmacy chains in Russia.
  • Levroso Long (Левросо® Лонг) Proprietary branded fixed-combination pharmaceutical for the treatment of insomnia, containing Diphenhydramine and Melatonin as active ingredients. Distributed through pharmaceutical wholesalers and pharmacy chains in Russia.

Companies that use NovaMedica

Customer profile

Segments3 records

Ideal customer profiles1 record

NovaMedica technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

NovaMedica partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights3 records

NovaMedica competitors and assessment

Company assessment

Direct peers

  • Pharmstandard: One of the largest Russian pharmaceutical manufacturers with a broad branded generics portfolio spanning CNS, pain, and other therapeutic areas. Directly comparable as a domestic Russian pharma producing and commercializing branded products in overlapping indications.
  • Valenta Pharm: Russian pharmaceutical company focused on branded prescription and OTC products including CNS and pain therapies. Comparable in business model, Russian-market focus, and branded product strategy.
  • OTCPharm: Russian pharma manufacturer and marketer of branded OTC and prescription products. Overlaps with NovaMedica on branded product strategy and Russian market distribution.
  • Veropharm: Russian pharmaceutical manufacturer with GMP production and a portfolio of branded generics. Comparable as a domestic pharma with integrated manufacturing and sales operations.
  • Polysan: Russian pharmaceutical manufacturer producing branded products including CNS therapies. Similar in size, GMP manufacturing, and Russian-market focus.

Broad incumbents

  • R-Pharm: Major Russian pharmaceutical company with a much broader portfolio across multiple therapeutic areas. Comparable as a Russian pharma incumbent but operates at significantly larger scale with broader R&D.
  • Biocad: Large Russian biopharmaceutical company with manufacturing and sales capabilities. Comparable as a Russian pharma manufacturer, though Biocad focuses more on biologics and biosimilars.

Regional players

  • Stada Arzneimittel: European generics and specialty pharma company with established operations in Russia and CIS. Comparable as a producer of branded generics with significant Russian-market presence.
  • Gedeon Richter: Hungarian-headquartered pharma with substantial Russian operations and a CNS-heavy portfolio. Comparable in therapeutic area overlap (CNS) and Russian-market exposure.
  • Krka: Slovenian generic pharma manufacturer with a strong presence in Russia/CIS markets. Comparable as a generics manufacturer with meaningful Russian revenue exposure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

NovaMedica social profiles

Digital presence

NovaMedica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NovaMedica leadership team

Management profile

Number of profiles

Profiles1 record

NovaMedica funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NovaMedica M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NovaMedica

What does NovaMedica do?

NovaMedica is a Russian pharmaceutical company that promotes and commercializes proprietary pharmaceutical products within Russia. It handles the full lifecycle from product registration and GMP-certified manufacturing to commercial sales. Its current portfolio consists of three drugs: Relonova (Rizatriptan-based migraine treatment), Difendum (Diclofenac potassium-based pain syndrome treatment), and Levroso Long (Diphenhydramine and Melatonin fixed-combination insomnia treatment).

Is NovaMedica a public or private company?

NovaMedica is a private company. It is classified as unknown and is currently operating.

When was NovaMedica founded?

NovaMedica was founded in 2012. It employs 51 to 100 people.

Where is NovaMedica based?

NovaMedica is headquartered in Moscow, Russia, in the Europe region.

How does NovaMedica make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are NovaMedica's main competitors?

Direct peers on record are Pharmstandard, Valenta Pharm, OTCPharm, Veropharm and Polysan. Broad incumbents are R-Pharm and Biocad. Regional players are Stada Arzneimittel, Gedeon Richter and Krka.

Does NovaMedica have an API?

No public API is recorded for NovaMedica.

What industry is NovaMedica in?

NovaMedica's product category is Prescription Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAN, Pain Management & Anesthesiology Pharmaceuticals, with a secondary code of HLAIAAAF, Neurology & Psychiatry (CNS) Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals